Back
iShares Paris-Aligned Clmt MSCI USA ETF Vs. Neurogene Industry Stock Comparison
Buy
95
PABU
iShares Paris-Aligned Clmt MSCI USA ETF
Last Price:
65.56
Seasonality Move:
13.32%
Sell
5
NGNE
Neurogene
Last Price:
39.96
Seasonality Move:
50.43%
Buy
95
iShares Paris-Aligned Clmt MSCI USA ETF (PABU)
is a Buy
Is iShares Paris-Aligned Clmt MSCI USA ETF a Buy, Sell or Hold?
- The current iShares Paris-Aligned Clmt MSCI USA ETF [PABU] share price is $65.70. The Score for PABU is 95, which is 90% above its historic median score of 50, and infers lower risk than normal.
- PABU is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PABU Stock Price Chart
What is iShares Paris-Aligned Clmt MSCI USA ETF's stock price today?
-
The iShares Paris-Aligned Clmt MSCI USA ETF share price today is $65.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PABU is experiencing buying pressure, which is a positive indicator for future bullish movement.
PABU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.64 | Buy |
Relative Strength Index (14 RSI): | 65.79 | Buy |
Chaikin Money Flow: | 19862 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.16 - 65.02) | Buy |
Bollinger Bands (100): | (59.85 - 63.75) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.3 | Buy |
Relative Strength Index (14 RSI): | 39.1 | Sell |
Chaikin Money Flow: | -346626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.29 - 61.53) | Sell |
Bollinger Bands (100): | (34.11 - 50.51) | Sell |
PABU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.88 | Buy |
20-day SMA: | 64.17 | Buy |
50-day SMA: | 63.26 | Buy |
200-day SMA: | 59.02 | Buy |
8-day EMA: | 65.07 | Buy |
20-day EMA: | 64.34 | Buy |
50-day EMA: | 63.3 | Buy |
200-day EMA: | 59.12 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.39 | Sell |
20-day SMA: | 53.17 | Sell |
50-day SMA: | 46.66 | Sell |
200-day SMA: | 38.93 | Buy |
8-day EMA: | 54.03 | Sell |
20-day EMA: | 53.18 | Sell |
50-day EMA: | 48.36 | Sell |
200-day EMA: | 38.47 | Buy |
iShares Paris-Aligned Clmt MSCI USA ETF Earnings Growth & PABU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
iShares Paris-Aligned Clmt MSCI USA ETF Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |